JAK2 and myeloproliferative neoplasm: “Driver” mutations in three genes (Janus kinase (JAK)2, calreticulin (CALR) and myeloproliferative leukemia virus oncogene (MPL)) that activate the JAK2 signaling pathway have been detected in MPN.